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• UMass Medical School granted five-year, $30 million Clinical and Translational Sciences 
Award 
• TL1 Trainee receives NCI F31 award 
• “Just-in-Time Alert” (JITA) Real Time Patient Recruitment Application 
 
COVID-19 
• Clinical Research Nurses Needed for RADx Studies 
• UMMS Update 
• NIH Update 
• COVID-19 Clinical Trials Database 
• The National COVID Cohort Collaborative (N3C) 
 
EVENTS 
• 2020 M2D2 $200K Challenge Pitch-Off and Award Celebration 
• Community Engagement and Research Symposium kickoff webinar 
 
FUNDING 
• CCTS SPARK Program (Small Pilot and Research Knowledge) 
• CCTS Small Conference Grants 
 
EDUCATION 
• Greater Worcester Covid-19 Survey 
 
DID YOU KNOW 
• HRPP QA/QI 
• National Center for Data to Health (CD2H)   
 
NEWS 
UMass Medical School granted five-year, $30 million Clinical and Translational 
Sciences Award: UMass Medical School will bring the UMass Center for Clinical and 
Translational Science to its next level of innovation and collaboration with the five-year, $30 
million renewal of its Clinical and Translational Sciences Award from the National Institutes of 
Health. The center advances clinical and translational research through education and 
training, pilot funding programs, research cores, and services. Read the full story here: 
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TL1 Trainee receives NCI F31 award: Maira Castañeda-Avila is interested in understanding 
how various factors, such as race, ethnicity, socioeconomic status, or cancer precursor 
diagnosis, influence healthcare utilization in the US and Puerto Rico.  Supported by the 
UMCCTS TL1 training program, she has been investigating how the role of a diagnosis of 
Monoclonal Gammopathy of Undetermined Significance (MGUS), an understudied precursor 
of multiple myeloma (MM), changes the way patients utilize health care.   
 
Her mentor Mara Epstein, ScD, a previous UMCCTS KL2 scholar, encouraged Ms. 
Castañeda-Avila to apply for the TL1 program. “The TL1 Fellowship has helped me to build a 
strong foundation in epidemiology and advanced analytic skills and has allowed me to 
participate in national conferences and access external courses and workshops,” Ms. 
Castañeda-Avila said.  She hopes that her research will lead to a better understanding of 
healthcare utilization patterns in a population diagnosed with a premalignant condition. 
Specifically, this research could elucidate potential clinical targets that may lead to 
improvement in the long-term overall health of patients with MGUS, and that could be the 
focus of future interventions. 
 
She received the Ruth L. Kirschstein National Research Service Individual Predoctoral 
Fellowship to Promote Diversity in Health-Related Research (F31) funded by the National 
Cancer Institute. which will further her development as an independent investigator and 
support her research. After completing her training, she plans to pursue a position as an 
independent investigator at an academic institution where she can conduct population-based 
research on health disparities, focused on cancer prevention among underserved populations 
with particular interest in Hispanic populations in the US and Latin America. 
 
“Just-in-Time Alert” (JITA) Real Time Patient Recruitment Application: Recruitment to 
clinical trials can be challenging especially when clinical trial teams are trying to identify 
potential study participants in real time, e.g. in an emergency department (ED) setting. In 
response to this challenge, Jomol Mathew, PhD and the UMCCTS Informatics and 
Recruitment Core Team designed, developed, and implemented a new strategy for real-time 
identification of potential study participants in health care settings.  Leveraging the electronic 
health record (EHR) system, the informatics team developed the “Just-in-Time Alert” (JITA) 
application which receives messages from the EHR, processes those messages, and 
provides real-time alerts to clinical trial teams.  After receiving an alert, the study team can 
approach and discuss the study with patients while they are still in the clinic, emergency 
room, or other health care settings.  
In the development phase, JITA was tested for its ability to enhance enrollment of an 
opioid tolerance study being conducted in the ED and a gastroenterology study.  JITA was 
able to help increase awareness of potential participants and enrollment.  More recently, JITA 
has been used to identify patients who were newly diagnosed with COVID-19 for potential 
enrollment in a diagnostic device study in the Rapid Acceleration of Diagnostics (RADx) 
initiative.  JITA was highly successful in identifying individuals with positive COVID results 
and notifying RADx study team members of potential study participants.  Mary Co, MD, an 
investigator on the RADx device study wrote to the JITA team, “It is really just in time - the 
patients were still in the ER!”  The UMCCTS Recruitment Core is collaborating with other 
CTSA’s to further develop and test JITA at other institutions who have similar EHRs and 
2
UMass Center for Clinical and Translational Science Newsletter, Vol. 2020 [2020], Iss. 9, Art. 1
https://escholarship.umassmed.edu/umccts_news/vol2020/iss9/1
DOI: 10.13028/qjt9-0440
processes.  A more detailed description of JITA can be found in Lee V, et al. JITA: A Platform 
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Clinical Research Nurses Needed for RADx Studies: The Center for Advancing Point of 
Care Therapeutics (CAPCaT) has been designated as a national test center for the NIH 
Rapid Acceleration of Diagnostics (RADx) program. Our Center is looking for experienced 
clinical research nurses with an interest in working with people undergoing COVID-19 testing 
to collect information and specimens in order to validate new and innovative test devices 
coming to UMass from around the world. The positions are available immediately. If you are 
interested or if you have any questions, please contact Danielle Howard 
(Danielle.howard@umassmed.edu) or apply at 
https://www.ummsjobs.com/job/5416/  or  https://www.ummsjobs.com/job/5000/ 
 
UMMS UPDATE regarding human subjects research during the COVID-19 pandemic can be 
found here: https://umassmed.edu/ccts/covid-19/. This website is updated frequently. 
 
NIH UPDATE: For up-to-date NIH COVID-19 information, including informational videos, 
proposal submission and award management resources, human subjects and clinical trials 
guidance, animal welfare, frequently asked questions regarding flexibilities for grantees, and 
funding opportunities, click here: https://www.nih.gov/health-information/coronavirus  
 
CLINICAL TRIALS DATABASE: To search for active Covid-19 clinical trials at UMMS, 
please visit https://www.conqueringdiseases.org/ . Conquering Diseases is an easy to use 
web-based search tool to find, share and save clinical studies relevant to patients. It also 
provides educational resources to help patients and families learn about and find clinical 
studies. It provides a patient-friendly and direct way to learn about clinical studies and a 
secure environment to share clinical study opportunities and communicate with study staff for 
screening and enrollment into clinical studies. 
THE NATIONAL COVID COHORT COLLABORATIVE (N3C): The National COVID Cohort 
Collaborative (N3C) Data Enclave is now open to scientists looking for evidence-based 
answers to COVID-19 research questions. This centralized and secure national data 
analytics platform is for COVID-19 research, including studying potential risk factors, 
protective factors and long-term health consequences, as the pandemic continues to evolve. 
Its data and analytics capabilities will grow over time. Learn more about the N3C data and 
applying for access. 
EVENTS 
2020 M2D2 $200K Challenge Pitch-Off and Award Celebration: M2D2 is thrilled to 
announce that we have officially rescheduled the 2020 M2D2 $200K Challenge Pitch-Off and 
Award Celebration—now virtual and free of charge. Mark your calendars:  
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Finalist Pitch-Off: Thursday, September 17 at 5pm ET 
Awards Celebration: Thursday, October 1 at 5 pm ET 
 
Register here to attend: https://www.eventbrite.com/e/2020-m2d2-200k-challenge-pitch-off-
awards-celebration-tickets-78510953375  
 
Community Engagement and Research Symposium kickoff webinar: The 9th Annual 
Community Engagement and Research Symposium will be a series of Webinars this year.  
Our first speaker is Peter D. Friedmann, MD, MPH, DFASAM, FACP. Title: The Opioid-
related Syndemic in Rural Northern New England: Findings from the DISCERNNE Study.  
Registration for the Keynote Speaker Webinar being held on September 22, 2020 from 1:00 – 




CCTS SPARK PROGRAM: Rolling application deadline.  This program’s priorities are to 
support studies that impact clinical care and research methodologies, support 
students/trainees, and provide access to funds to generate pilot and preliminary data for 
external grant submissions.  For more information, click on this link: 
https://www.umassmed.edu/ccts/funding/spark-program/ 
 
CCTS SMALL CONFERENCE GRANTS: Rolling application deadline.  This funding 
facilitates the development of faculty-to-faculty networks within the University system.  Click 
on this link for more information: https://umassmed.edu/ccts/funding/small-conference-grants/ 
FUNDING OPPORTUNITY: postdoctoral fellowships to prepare the next generation of 
scientists to conduct implementation research that addresses critical cancer prevention and 
control care delivery issues. 
  
EDUCATION 
GREATER WORCESTER COVID-19 COMMUNITY HEALTH SURVEY: UMass Medical 
School, in collaboration with the City of Worcester and the Central Massachusetts Regional 
Public Health Alliance is conducting the Great Worcester COVID-19 Community Health 
Survey.  The online survey, which takes about 10 minutes to complete, asks respondents 
about changes in their lives due to COVID since March 10, including their health, finances, 
activities outside the home, access to medical care, employment, housing and food security. 
The names of the street a respondent lives on and the closest cross street will be vital for 
understanding circumstances in specific neighborhoods. Providing contact information is 
optional for respondents who want to receive survey results, and who are willing to be 
contacted about the survey. The survey also provides a list of local resources for households 
experiencing distress due to COVID-19. The survey is available in English, Spanish, 
Portuguese, Vietnamese, Albanian and Russian. To participate, please click here. 
DID YOU KNOW? 
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HRPP QA/QI: The Human Research Protection Program (HRPP) Quality Assurance/Quality 
Improvement (QA/QI) Program is a component of the UMass Center for Clinical and 
Translational Science. The program is independent of the IRB and helps study teams and 
investigators by conducting routine post-approval monitoring of on-going research to evaluate 
adherence with institutional requirements and federal regulations. If there are review findings, 
the QA/QI manager shares those findings with investigators and study teams, and provides 
direct education on the findings, including how to avoid making similar errors in the future. In 
order to support improvement at an institutional level, the QA/QI manager shares aggregated 
data from reviews with the HRPP leadership and the Research Community to identify trends 
and target areas for education. The program also makes self-evaluation tools available to 
investigators and study teams seeking to perform their own assessments.  To learn more 
about HRPP QA/QI HRP-142, visit: https://www.umassmed.edu/globalassets/ccts/ccts-
media/irb/updated-sops-2015/hrp-142-hrpp-qa-qi-program-final.pdf. 
 
NATIONAL CENTER FOR DATA TO HEALTH (CD2H): The goal of CD2H is to make data 
more meaningful, open and accessible. The CD2H supports a vibrant and evolving 
collaborative informative ecosystem for the CTSA program and beyond. The CD2H 
harnesses and expands an ecosystem for translational scientists to discover and share their 
software, data and other research resources within the CTSA program network.  The CD2H 
also creates a social coding environment for translational science institutions, leveraging the 
community-driven DREAM challenges as a mechanism to stimulate innovation. To learn 
more, click here. 
 
SHARE YOUR SUCCESS STORY 
Have you had your research published that cites the UMass Center for Clinical and 
Translational Science?  Has your patent been filed on technology developed using Center 
funding or resources? Did your pilot project receive external grant funding? Share it with us at 
ccts@umassmed.edu. Sharing your success demonstrates the importance and effect of the 
Center for Clinical and Translational Science at UMass. 
 
 
CITE & SUBMIT 
Please cite the NIH CTSA award any time you use The UMMS Center for Clinical and 
Translational Science resources, services and facilities or received funding through the 
Center. “The project described is supported by the National Center for Advancing 
Translational Sciences, National Institutes of Health, through Grant UL1 TR001453, (or 
TL1 TR001454, or KL2 TR001455, as appropriate). The content is solely the 
responsibility of the authors and does not necessarily represent the official views of 
the NIH.”  
 
Newsletter Submissions: To be included in the CCTS Monthly Newsletter, please send 
announcements, including a link, to ccts@umassmed.edu. The newsletter is published the 
first week of each month. 
 
University of Massachusetts Center for Clinical and Translational Science, 55 Lake Avenue N, Worcester MA 
01655 
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